This page shows the latest symptoms news and features for those working in and with pharma, biotech and healthcare.
The trial met all of its primary and key secondary endpoints, with Ojjaara-treated patients showing improved symptoms, spleen size and transfusion independent compared with patients receiving danazol.
As a challenging condition to diagnose, varying symptoms and early signs of the condition such as tremors, stiffness and slowness, are primarily relied on in order to diagnose patients. ... However, symptoms often appear many years after the onset of PD.
The study met its primary endpoint, with a greater proportion of patients treated once-daily with TAK-279 achieving at least a 20% improvement in signs and symptoms of disease at
Crohn’s disease is a chronic, progressive condition of the digestive system, causing symptoms such as persistent diarrhoea and abdominal pain.
9.7 months for Lu-PSMA-dosed patients’ quality of life to worsen and 14.3 months for symptoms to worsen, compared to 2.4 months and 2.9 months for
The approval was supported by results from two phase 3 trials in which Bimzelx showed improvements over placebo in joint and skin symptoms across biologic naïve and TNF inhibitor-inadequate responder ... symptoms and disease activity across the full
More from news
Approximately 3 fully matching, plus 1,593 partially matching documents found.
Using the tool exercises the muscles in the face, helping delay symptoms of muscle atrophy.
them recognise symptoms and diagnose the condition early.
Essentially, a patient pathway is the journey of patients through a healthcare system, usually within a specific disease area, from people’s recognition of symptoms, leading to their first contact with ... Because administration of innovative SMA
such as levodopa and COMT inhibitors, that can help manage the symptoms of the disease. ... convenient and tolerable agents to manage the symptoms of Parkinson’s disease is an unmet need that can hopefully be answered.
They explained how their initial symptoms, often blurred vision, were ignored and misdiagnosed, and how they struggled with uncertainty before getting a diagnosis and treatment. ... It has been a good opportunity and it can lead to positive benefits and
More from intelligence
Approximately 0 fully matching, plus 164 partially matching documents found.
Acadia is at the forefront in developing groundbreaking medicines to treat debilitating symptoms associated with these diseases.
Nicholas has previously specialised in the provision of medical devices designed to help manage screening, symptoms and treatment.
San Francisco-based Gemmus was founded in 2007 and is developing a drug that decreases the severity of flu symptoms by modulating the release of pro-inflammatory cytokines.
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Symptoms are broad and can vary dramatically in severity, often leaving doctors mystified whilst patients suffer.
Furthermore, 69% agreed there should be more treatments available for the symptoms of menopause. ... symptoms of menopause, and how she and her family come to accept it.
2) The child may display a variety of different symptoms which do not match one disorder and a clear diagnosis is not reached. ... 3) The child might have an array of symptoms that are in fact an unusual presentation of a known rare condition.
Users are first asked to input dates of their menstrual periods along with information on their symptoms. ... on the subject – giving women access to someone who they know will take their symptoms seriously.
The nocebo effect is described as a phenomenon “causing patients to develop side effects or unwanted symptoms, or reject treatment, due to the belief that the medical intervention will cause harm.”
More from PMHub
Approximately 0 fully matching, plus 186 partially matching documents found.
No results were found
Genesis Research is an international HEOR and RWE research organization. A leader in evidence strategy, generation and communication, the company...